Colín MDH, Romo AC

Language: Spanish
References: 12
Page: 7-10
PDF size: 119.78 Kb.

ABSTRACT

Introduction: Abnormal uterine bleeding is the second cause of gynecological consultation and many times its diagnosis or treatment may be related to oncological diseases or require a surgical approach for treatment require immediate access so the clinical assessment is very important. Material and methods: Cross-sectional, observational and retrospective study that evaluated women between the ages of 25-60 years treated at the Ángeles Pedregal Hospital between January 2014 and June 2017 due to abnormal uterine bleeding. They required surgical intervention and a sample was sent for anatomopathological analysis as a diagnostic method. Results: We studied 276 cases of women of average age of 42.9 years, of which 39.7% have not presented a pregnancy. 56.23% of the deeds have been resolved by caesarean sections. 47.6% of the surgical interventions were performed by laparoscopy. Of the 261 cases of leiomyoma diagnosed by tissue sample, 91.5% were clinically diagnosed; however, only 11.26% of the cases of adenomatosis were clinically identified. Conclusion: Despite advances in diagnostic algorithms and the use of cabinet techniques, anatomopathological diagnosis in abnormal uterine bleeding is vital for an accurate diagnosis.

REFERENCES

1. Munro MG, Critchley HO, Fraser IS, Group FMDW. The FIGO classification of causes of abnormal uterine bleeding in the reproductive years. Fertil Steril. 2011; 95 (7): 2204-2208, 8 e1-3.

2. DeCherney AH Nathan L, Laufer N, Roman AS. Diagnóstico y tratamiento ginecoobstétricos .11a. ed. Mexico: McGraw Hill; 2014.

3. Munro MG, Critchley H, Fraser IJRdc. La clasificación FIGO de causas de sangrado uterino anormal en los años reproductivos. Revista del Climaterio. 2011; 15 (85): 9-17.

4. Palep-Singh M, Prentice A. Epidemiology of abnormal uterine bleeding. Best Pract Res Clin Obstet Gynaecol. 2007; 21 (6): 887-890.

5. Moradan S, Ghorbani R, Lotfi A. Agreement of histopathological findings of uterine curettage and hysterectomy specimens in women with abnormal uterine bleeding. Saudi Med J. 2017; 38 (5): 497-502.

6. Vercellini P, Consonni D, Dridi D, Bracco B, Frattaruolo MP, Somigliana E. Uterine adenomyosis and in vitro fertilization outcome: a systematic review and meta-analysis. Hum Reprod. 2014; 29 (5): 964-977.

7. Abbott JA. Adenomyosis and Abnormal Uterine Bleeding (AUB-A)-Pathogenesis, diagnosis, and management. Best Pract Res Clin Obstet Gynaecol. 2017; 40: 68-81.

8. Hulka CA, Hall DA, McCarthy K, Simeone J. Sonographic findings in patients with adenomyosis: can sonography assist in predicting extent of disease? AJR Am J Roentgenol. 2002; 179 (2): 379-383.

9. Panduro B, Guadalupe J, Pérez M, Jesús J, Panduro EG, Castro JF et al. Factores de riesgo prenatales en la muerte fetal tardía, Hospital Civil de Guadalajara, México. Rev Chil Obstet Gineco. 2011; 76 (3): 169-174.

10. Learman LA, Nakagawa S, Gregorich SE, Jackson RA, Jacoby A, Kuppermann M. Success of uterus-preserving treatments for abnormal uterine bleeding, chronic pelvic pain, and symptomatic fibroids: age and bridges to menopause. Am J Obstet Gynecol. 2011; 204 (3): 272 e1-7.

11. Carlson KJ, Miller BA, Fowler FJ, Jr. The Maine Women’s Health Study: II. Outcomes of nonsurgical management of leiomyomas, abnormal bleeding, and chronic pelvic pain. Obstet Gynecol. 1994; 83 (4): 566-572.

12. Bacon JL. Abnormal Uterine Bleeding: Current Classification and Clinical Management. Obstet Gynecol Clin North Am. 2017; 44 (2): 179-193.